National Health (Take Home Naloxone) Special Arrangement 2019
7Definition of special arrangement supply
Start here
Get a plain-English read of 7
Turn the raw legal text into a practical explanation grounded in National Health (Take Home Naloxone) Special Arrangement 2019.
7 Definition of special arrangement supply
Supplies by approved hospital authorities (1) A supply of a designated pharmaceutical benefit is a special arrangement supply of the benefit if the benefit is supplied: (a) either: (i) in New South Wales, Western Australia or South Australia on or after 1 December 2019; or (ii) in Victoria, Queensland, Tasmania or a Territory on or after 1 July 2022; and (c) by an approved hospital authority that is not an excluded approved supplier; and (d) to a designated person who, at the time of the supply, is: (i) a day admitted patient of a hospital of which the approved hospital authority is the governing body or proprietor; or (ii) a patient on discharge from such a hospital; or (iii) a non‑admitted patient of such a hospital; or (iv) not a patient receiving treatment in or at such a hospital; and (e) without a prescription. Supplies by approved medical practitioners (2) A supply of a designated pharmaceutical benefit is also a special arrangement supply of the benefit if: (aa) the benefit is supplied: (i) in New South Wales, Western Australia or South Australia on or after 1 December 2019; or (ii) in Victoria, Queensland, Tasmania or a Territory on or after 1 July 2022; and (a) the benefit is supplied: (iii) to a designated person; and (iv) without a prescription; and (v) by an approved medical practitioner who is not an excluded approved supplier; and (b) the benefit was not obtained by the approved medical practitioner under section 93 of the Act (prescriber bag supplies). Supplies by approved pharmacists (3) A supply of a designated pharmaceutical benefit is also a special arrangement supply of the benefit if the benefit is supplied: (a) either: (i) in New South Wales, Western Australia or South Australia on or after 1 December 2019; or (ii) in Victoria, Queensland, Tasmania or a Territory on or after 1 July 2022; and (c) to a designated person; and (d) without a prescription; and (e) by an approved pharmacist who is not an excluded approved supplier. Supplies by authorised alternative suppliers (4) A supply of a designated pharmaceutical benefit is also a special arrangement supply of the benefit if the benefit is supplied: (a) either: (i) in New South Wales, Western Australia or South Australia on or after 1 December 2019; or (ii) in Victoria, Queensland, Tasmania or a Territory on or after 1 November 2022; and (c) to a designated person; and (d) by an authorised alternative supplier. (5) However, a supply of a designated pharmaceutical benefit mentioned in subsection (4) is not a special arrangement supply of the benefit if: (a) the authorised alternative supplier is the ambulance service of a jurisdiction; and (b) the benefit supplied is administered to the designated person by an ambulance officer to treat the person for an opioid overdose.